These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2298201)

  • 1. Inhibition of leukotriene omega-oxidation by isonicotinic acid hydrazide (isoniazid).
    Parthé S; Hagmann W
    Eur J Biochem; 1990 Jan; 187(1):119-24. PubMed ID: 2298201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Halothane metabolism. Impairment of hepatic omega-oxidation of leukotrienes in vivo and in vitro.
    Huwyler J; Jedlitschky G; Keppler D; Gut J
    Eur J Biochem; 1992 Jun; 206(3):869-79. PubMed ID: 1318837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethanol-induced inhibition of leukotriene degradation by omega-oxidation.
    Baumert T; Huber M; Mayer D; Keppler D
    Eur J Biochem; 1989 Jun; 182(2):223-9. PubMed ID: 2544422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.
    Jedlitschky G; Huber M; Völkl A; Müller M; Leier I; Müller J; Lehmann WD; Fahimi HD; Keppler D
    J Biol Chem; 1991 Dec; 266(36):24763-72. PubMed ID: 1761571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-oxidation of cysteine-containing leukotrienes by rat-liver microsomes. Isolation and characterization of omega-hydroxy and omega-carboxy metabolites of leukotriene E4 and N-acetylleukotriene E4.
    Orning L
    Eur J Biochem; 1987 Dec; 170(1-2):77-85. PubMed ID: 2826163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of leukotriene omega-oxidation by omega-trifluoro analogs of leukotrienes.
    Jedlitschky G; Leier I; Huber M; Mayer D; Keppler D
    Arch Biochem Biophys; 1990 Nov; 282(2):333-9. PubMed ID: 2173482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia and CCl4-induced liver injury, but not acidosis, impair metabolism of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Hepatology; 1990 May; 11(5):866-73. PubMed ID: 2161395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of sinusoidal uptake and biliary excretion of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Eur J Biochem; 1990 Jul; 191(1):251-5. PubMed ID: 2165907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic inactivation of leukotrienes.
    Keppler D; Huber M; Baumert T; Guhlmann A
    Adv Enzyme Regul; 1989; 28():307-19. PubMed ID: 2624175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography.
    Guhlmann A; Krauss K; Oberdorfer F; Siegel T; Scheuber PH; Müller J; Csuk-Glänzer B; Ziegler S; Ostertag H; Keppler D
    Hepatology; 1995 Jun; 21(6):1568-75. PubMed ID: 7768501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
    Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
    Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
    Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation of P450-dependent oxidation of isoniazid in isonicotinic acid formation in rat liver.
    Ono Y; Wu X; Noda A; Noda H; Yoshitani T
    Biol Pharm Bull; 1998 Apr; 21(4):421-5. PubMed ID: 9586587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake, production and metabolism of cysteinyl leukotrienes in the isolated perfused rat liver. Inhibition of leukotriene uptake by cyclosporine.
    Hagmann W; Parthé S; Kaiser I
    Biochem J; 1989 Jul; 261(2):611-6. PubMed ID: 2549977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of 12(R)-hydroxyeicosatetraenoic acid by rat liver microsomes.
    Jajoo HK; Capdevila JH; Falck JR; Bhatt RK; Blair IA
    Biochim Biophys Acta; 1992 Jan; 1123(1):110-6. PubMed ID: 1730042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes.
    Stene DO; Murphy RC
    J Biol Chem; 1988 Feb; 263(6):2773-8. PubMed ID: 2830262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal leukotriene degradation: biochemical and clinical implications.
    Jedlitschky G; Mayatepek E; Keppler D
    Adv Enzyme Regul; 1993; 33():181-94. PubMed ID: 8356907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo formation of omega-oxidized metabolites of leukotriene C4 in the rat.
    Orning L; Keppler A; Midtvedt T; Hammarström S
    Prostaglandins; 1988 Apr; 35(4):493-501. PubMed ID: 3247468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic uptake and metabolic disposition of leukotriene B4 in rats.
    Hagmann W; Korte M
    Biochem J; 1990 Apr; 267(2):467-70. PubMed ID: 2159284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo].
    Keppler D
    Klin Wochenschr; 1988 Oct; 66(20):997-1005. PubMed ID: 3070147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.